Drug interactions for the following drug(s)

Interactions between your selected drugs

The excretion of Ezetimibe can be decreased when combined with Valsartan.

Hydrochlorothiazide may decrease the excretion rate of Potassium chloride which could result in a higher serum level.

The excretion of Ezetimibe can be decreased when combined with Levothyroxine.

Amlodipine may increase the hyperkalemic activities of Potassium chloride.

The metabolism of Levothyroxine can be decreased when combined with Atorvastatin.

The excretion of Atorvastatin can be decreased when combined with Valsartan.

The excretion of Valsartan can be decreased when combined with Levothyroxine.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Drug1 (rxcui = 349556, name = ezetimibe 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 636045, name = hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet, tty = SCD). Drug1 is resolved to valsartan, Drug2 is resolved to ezetimibe and interaction asserted in DrugBank between Valsartan and Ezetimibe.

Drug1 (rxcui = 636045, name = hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1801295, name = Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet [Klor-Con], tty = SBD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Hydrochlorothiazide and Potassium chloride. Drug1 is resolved to potassium chloride, Drug2 is resolved to valsartan and interaction asserted in DrugBank between Potassium chloride and Valsartan.

Drug1 (rxcui = 349556, name = ezetimibe 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to ezetimibe and interaction asserted in DrugBank between Levothyroxine and Ezetimibe.

Drug1 (rxcui = 197361, name = amlodipine 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1801295, name = Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet [Klor-Con], tty = SBD). Drug1 is resolved to potassium chloride, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Potassium chloride and Amlodipine.

Drug1 (rxcui = 617310, name = atorvastatin 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Levothyroxine and Atorvastatin.

Drug1 (rxcui = 617310, name = atorvastatin 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 636045, name = hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet, tty = SCD). Drug1 is resolved to valsartan, Drug2 is resolved to atorvastatin and interaction asserted in DrugBank between Valsartan and Atorvastatin.

Drug1 (rxcui = 636045, name = hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to valsartan and interaction asserted in DrugBank between Levothyroxine and Valsartan.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.